CLAIM #3398 · Abbott Laboratories (ABT) · 2026Q2 earnings call · Jul 16, 2026 · due Dec 31, 2026
“our deal model, that we put together to support the acquisition, for 2026 had mid-teens. I feel confident that we will achieve that.”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2026 are reported
How to check this claim
Look at: Metric implied by 'mid-teens' in the acquisition deal model for 2026 (likely growth rate or margin, as disclosed by company) — presumed to be a percentage growth/margin figure referenced in the deal model
It came true if: 2026 figure for the referenced metric falls within 14%-17% (mid-teens range)
Where: Company earnings release, 10-K, or management commentary disclosing 2026 results for the metric referenced
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2026Q2 earnings call.